Ignite Creation Date:
2024-05-06 @ 11:01 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03414034
Status:
COMPLETED
Last Update Posted:
2023-11-01
First Post:
2018-01-22
Brief Title:
Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Cardiff Oncology
Organization:
Cardiff Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-18
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-16
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-22
First Submit QC Date:
January 26 2018
Study First Post Date:
2018-01-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-31
Last Update Post Date:
2023-11-01
Last Update Post Date Type:
ACTUAL